Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 169

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

A Phase I/II Clinical Trial of β‐Globin Gene Therapy for β‐Thalassemia

BANK, ARTHUR, DORAZIO, RONALD, LEBOULCH, PHILIPPE · 2005 · Annals of the New York Academy of Sciences

Abstract

A bstract: Recent success in the long‐term correction of mouse models of human β‐thalassemia and sickle cell anemia by lentiviral vectors and evidence of high gene transfer and expression in transduced human hematopoietic cells have led to a first clinical trial of gene therapy for the disease. A LentiGlobin vector containing a β‐globin gene (β A‐T87Q) that produces a hemoglobin (Hbβ A‐T87Q) that can be distinguished from normal hemoglobin will be used. The LentiGlobin vector is self‐inactivating and contains large elements of the β‐globin locus control region as well as chromatin insulators and other features that should prevent untoward events. The study will be done in Paris with Eliane Gluckman as the principal investigator and Philippe Leboulch as scientific director.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1196/annals.1345.007

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 169

Metadata

Authors
BANK, A., DORAZIO, R., & LEBOULCH, P.
Venue
Annals of the New York Academy of Sciences
Publisher
Wiley
Published
2005-11
Volume
1054
Issue
1
Pages
308-316
ISSN
  • 0077-8923 (ISSN-L)
  • 1749-6632
OpenAlex
W2160888392
Cited by
169
References
2
FWCI
5.88
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Phase I/II Clinical Trial of β‐Globin Gene Therapy for β‐Thalassemia. https://app.cochat.ai/papers/10.1196/annals.1345.007
The paper
BANK, A., DORAZIO, R., & LEBOULCH, P. (2005). A Phase I/II Clinical Trial of β‐Globin Gene Therapy for β‐Thalassemia. Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1345.007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.